Number of Shares
10.95 Mil
Current Holdings Value*
$23.98 Mil
% of Portfolio
5.86%
Total Estimate Gain
$-7.34 Mil
% of Total Estimate Gain
-26.69%

Sands Capital Ventures, LLC's Inhibikase Therapeutics Inc Holding Summary

As of 2025-03-31, Sands Capital Ventures, LLC held 10.95 Mil shares of Inhibikase Therapeutics Inc(IKT), totaling $23.98 Mil. This investment constitutes 5.86% of their stock portfolio, and Sands Capital Ventures, LLC now holds 14.73% of the outstanding Inhibikase Therapeutics Inc(IKT) stock.

The initial trade took place in 2024Q4. And since then Sands Capital Ventures, LLC has made 1 purchases of IKT, at an average price of $2.51, for a total of 10.95 Mil shares. Based on historical transaction data and IKT's current price of $1.84, Sands Capital Ventures, LLC's estimated gain on his IKT holdings is $-7.34 Mil, reflecting a -26.69% gain to date.

Sands Capital Ventures, LLC IKT ($1.84) Holding Chart

Sands Capital Ventures, LLC IKT ($1.84) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1